Growth Metrics

Pulmonx (LUNG) Non-Current Deferred Tax Liability (2019 - 2025)

Pulmonx has reported Non-Current Deferred Tax Liability over the past 7 years, most recently at $69000.0 for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 20.69% to $69000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $69000.0 through Dec 2025, down 20.69% year-over-year, with the annual reading at $69000.0 for FY2025, 20.69% down from the prior year.
  • Non-Current Deferred Tax Liability was $69000.0 for Q4 2025 at Pulmonx, up from $47000.0 in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $140000.0 in Q1 2024 and troughed at $37000.0 in Q4 2021.
  • The 5-year median for Non-Current Deferred Tax Liability is $71000.0 (2021), against an average of $79000.0.
  • Year-over-year, Non-Current Deferred Tax Liability soared 154.05% in 2022 and then plummeted 65.25% in 2025.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $37000.0 in 2021, then skyrocketed by 154.05% to $94000.0 in 2022, then rose by 21.28% to $114000.0 in 2023, then fell by 23.68% to $87000.0 in 2024, then dropped by 20.69% to $69000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Non-Current Deferred Tax Liability are $69000.0 (Q4 2025), $47000.0 (Q3 2025), and $41000.0 (Q2 2025).